Comparison of Early Postoperative Outcomes after Total Gastrectomy and D2 Lymph Node Dissection with and without Splenectomy
Musa Akoglu, Ilter Ozer, Murat Ulas, Volkan Oter, Tahsin Dalgic, Kadri Colakoglu, Murat Cayci, Erdal B Bostanci
Gastric cancer surgery, Postoperative outcomes, Splenectomy, Total gastrectomy
Citation Information :
Akoglu M, Ozer I, Ulas M, Oter V, Dalgic T, Colakoglu K, Cayci M, Bostanci EB. Comparison of Early Postoperative Outcomes after Total Gastrectomy and D2 Lymph Node Dissection with and without Splenectomy. Euroasian J Hepatogastroenterol 2018; 8 (2):108-111.
Background: A famous prognostic ingredient for gastric cancer is the lymph node metastasis. Previously in the therapy of gastric cancer, splenectomy was considered as a definitive part of lymph node dissection. Currently, preservation of the spleen is the accepted approach during total gastrectomy and routine splenectomy is abandoned. The aim of this study was to estimate the impression of splenectomy for D2 lymph node dissection with total gastrectomy.
Methodology: Between February 1998 and January 2012, 1531 patients underwent gastric cancer surgery. Of these 257 patients, 205 patients underwent total gastrectomy with splenectomy, and the remaining 52 underwent a spleen-preserving total gastrectomy.
Results: No statistical difference between these two groups in terms of age, gender, comorbidity, stage and American Society of Anesthesiologists score, surgical complications were detected. A significant difference was not seen in these groups with regard to postoperative mortality too.
Conclusion: Early postoperative results were similar after TG ± splenectomy. Performing splenectomy did not increase the postoperative morbidity and mortality.
Toge T, Kameda A, Kuroi K, Seto Y, Yamada H, Hattori T. The role of the spleen in immunosuppression and the effects of splenectomy on prognosis in gastric cancer patients. Nihon Geka Gakkai Zasshi 1985;86(9):1120-1123.
Ikeguchi M, Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer. Am Surg 2004;70:645- 648.
Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908-914.
Wu CW, Chang IS, Lo SS, Hsieh MC, Chen JH, Lui WY, et al. Complications following D3 gastrectomy: post hoc analysis of a randomized trial. World journal of surgery. 2006 Jan 1;30(1):12-16.
Fang WL, Huang KH, Wu CW, Chen JH, Lo SS, Hsieh MC, et al. Combined splenectomy does not improve survival in radical total gastrectomy for advanced gastric cardia cancer. Hepato-gastroenterology. 2012 Jun;59(116):1150-1154.
Mori EG, Celis J, Ruiz E, Payet E, Berrospi F, Chavez I, et al. Impact of splenectomy and/or distal pancreatectomy in the prognosis of the proximal gastric cancer. Revista de gastroenterologia del Peru: organo oficial de la Sociedad de Gastroenterologia del Peru. 2012;32(1):32-43.
Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, et al. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer. Hepatogastroenterology. 2004;51(55):298-302.
Brar SS, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N. A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer. Gastric Cancer. 2012 Sep 1;15(1):89-99.
Kunisaki C, Makino H, Suwa H, Sato T, Oshima T, Nagano Y, et al. Impact of splenectomy in patients with gastric adenocarcinoma of the cardia. Journal of Gastrointestinal Surgery. 2007 Aug 1;11(8):1039-1044.
Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, et al. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer. 2013 Oct 1;16(4):590-595.
Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomyversus splenic preservation in patients with proximal gastric cancer. British Journal of Surgery 2006;93(5):559-563.
Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, et al. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric cancer. 2011 Jun 1;14(2):172 -177.
Yang K, Chen XZ, Hu JK, Zhang B, Chen ZX, Chen JP. Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis. World journal of gastroenterology: WJG. 2009 Nov 14;15(42):5352-5359.
Yao XX, Sah BK, Yan M, Chen MM, Zhu ZG. Radical gastrectomy with combined splenectomy: unnecessary. Hepatogastroenterology. 2011 May 1;58(107-108):1067-1070.
Nashimoto A, Yabusaki H, Matsuki A. The significance of splenectomy for advanced proximal gastric cancer. International journal of surgical oncology. 2012;2012.
Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. The American Journal of Surgery 2009;198:25-30.
Ozer I, Bostanci EB, Koc U, Karaman K, Ercan M, Ulas M, et al:. Surgical treatment for gastric cancer in Turkish patients over age 70: early postoperative results and risk factorsfor mortality. Langenbecks Arch Surg 2010;395:1101-1106.